ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
72 hedge funds and large institutions have $21.5M invested in Aralez Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
57% less capital invested
Capital invested by funds: $50.2M → $21.5M (-$28.7M)
Holders
72
Holding in Top 10
–
Calls
$88K
Puts
$159K
Top Buyers
| 1 | +$343K | |
| 2 | +$306K | |
| 3 | +$270K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$159K |
| 5 |
BlackRock
New York
|
+$102K |
Top Sellers
| 1 | -$5.33M | |
| 2 | -$4.26M | |
| 3 | -$1.5M | |
| 4 |
AC
Armistice Capital
New York
|
-$1.5M |
| 5 |
PP
Prospector Partners
Guilford,
Connecticut
|
-$483K |